Toshiya Kagoo
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Chronic-phase chronic myeloid leukemia complicated by dasatinib-associated lymphadenopathy
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: August 30, 2026
Bortezomib With High-dose Melphalan Conditioning Regimen in Newly Diagnosed Multiple Myeloma Patients: Long-term Follow-up.
Journal: In vivo (Athens, Greece)
Published: August 31, 2024
Long-term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open-label extension study following a phase 3 placebo-controlled, double-blind, parallel-group study.
Journal: American journal of hematology
Published: August 16, 2023
Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: A phase 3, placebo-controlled, double-blind, parallel-group study.
Journal: British journal of haematology
Published: July 12, 2022
Discordant lymphoma of diffuse large B-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified in a human T-cell leukemia virus type-I carrier
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: October 07, 2021
Alternating bortezomib-dexamethasone and lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma aged over 75 years.
Journal: Nagoya journal of medical science
Published: November 25, 2020
Safety and Effectiveness of Ixazomib Dose-escalating Strategy in Ixazomib-Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma.
Journal: In vivo (Athens, Greece)
Published: May 01, 2020
Intravenous itraconazole compared with liposomal amphotericin B as empirical antifungal therapy in patients with neutropaenia and persistent fever.
Journal: Mycoses
Published: November 19, 2019
Occurrence of acquired factor V inhibitor during antibiotic therapy for a surgical wound infection
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: September 07, 2018
Bridging-to-transplant with Azacitidine for Myelodysplastic Syndrome and Acute Myeloid Leukemia, Reduces the Incidence of Acute Graft-versus-host Disease.
Journal: Hematology reports
Published: March 05, 2017
Relapsed/refractory multiple myeloma with CD138 shedding and formation of extramedullary disease in the common bile duct region presenting as obstructive jaundice
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: September 09, 2015
Azacitidine as the post-remission therapy for elderly patients with acute myeloid leukemia.
Journal: Annals of hematology
Published: May 19, 2014
Last Updated: 09/26/2026